-
Unclear Pronunciation of Stop Consonant Sounds in Patients with Parkinson’s Disease Following Deep Brain Stimulation
-
Understanding the Needs and Concerns of Newly Diagnosed People with Parkinson’s Disease
-
Unilateral delivery of cell-based therapy to the putamen and substantia nigra in patients with Parkinson’s disease who have an existing DBS system
-
Unilateral increase of blink reflex recovery cycle in drug-naive hemiparkinson syndrome.
-
Unilateral Leg Freezing in Moyamoya Syndrome
-
Unilateral leg tremor on sitting crossed-legged position as the initial manifestation of Parkinson’s disease
-
Unraveling biological processes implicated in MSA and PD by transcriptomic analysis
-
Unscheduled disruption of Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD)
-
Unusual expression of fragile X premutation in a female patient: clinical and tractographic description
-
Update from the international MDSGene initiative: International team science to perform genotype-phenotype correlations for hereditary movement disorders
-
Urodynamic study to distinguish multiple system atrophy from Parkinson’s disease
-
Use digital sensor and deep learning to evaluate motor performance in the D1PAM (LY3154207) phase 1B Parkinson’s disease clinical trial
-
Use of Chemodenervation for Secondary Limb Dystonia in Parkinson’s Disease: A Single Center Experience
-
Use of directional stimulation to localize and troubleshoot STN-related contralateral gaze deviation: a case report
-
Use of e-PROMs in Parkinson’s disease clinics: A qualitative study of healthcare professionals perceptions
-
Use of Inappropriate Antipsychotics Among US Long-Term Care Residents with Parkinson’s Disease Psychosis
-
Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson’s disease
-
Use of syringe driver in End of Life Care in Parkinson’s Disease (PD)
-
Usefulness of Cardiac MIBG Scintigraphy, DAT scan and midbrain/pontine ratio to differentiate Parkinson disease from atypical parkinsonian syndrome
-
Usefulness of Heart Rate Variability to Identify the Risk of Falling in Huntington’s Disease
-
Using Brain Atrophy and Visual Dysfunction to Predict Dementia in Parkinson’s Disease
-
Using cognitive computing to identify existing drugs with potential to stabilize mitophagy pathways associated with Parkinson’s Disease
-
Using functional status to aid interpretation of cUHDRS scores in patients with Huntington’s disease
-
Using Quantitative Susceptibility Mapping to Predict Dementia in Parkinson’s Disease
-
Using whole genome sequencing and intronic sequence analysis to identify pathogenic variants in Parkin-related Parkinson’s Disease
-
Utilising Magnetic Resonance Spectroscopy to investigate synucleinopathies
-
Utility of a smartphone app in discretely assessing and monitoring symptoms of Parkinson’s disease
-
Utility of Eye Movement Abnormalities in Differentiating Neurodegenerative versus non-Neurodegenerative Parkinsonism
-
Utilization of Monotherapy and Combination Therapies in Advanced Parkinson Disease Patients During Levodopa-Carbidopa Intestinal Gel Treatment from the COSMOS Study
-
Utilization patterns of Amantadine in Parkinson’s Disease patients enrolled in the French COPARK study
2019 International Congress
September 22-26, 2019. Nice, France.